U.S. Markets closed

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.87-0.12 (-1.72%)
At close: 4:00PM EDT
People also watch
EPZMVSTMCEMPRGLSCLRB
  • D
    DrrJohn
    DrrJohn
    The past couple of days (and yesterday in particular) have been terrible for small cap biotech. In fact, if you looks at the individual share prices, many smalls caps are at record lows.
    CCXI's share price might have been falling off the cliff mainly for sector reasons. However, it might also be related to Achillion's (ACHN) release of early clinical data of its oral Factor D inhibitor. I don't know how many realize that this factor D inhibitor targets much of the same markets as CCXI's oral C5aR-Inhibitor acavopan (pex G3-glomerulopathy). I wondered that neither analysts attending CCXI's CC, nor those attending ACHN's CC did ask any question about the competitor's compound,(p.ex, how both companies intend to deal with the struggle to get those rare patients with C3-glomerulopathy into their clinical trials). But then again, I doubt that those analysts (and the Street) are so ill informed... In the end, if CCXI's fire-sale was indeed related to ACHN's news, then the parallel path of those two companies must be well known. On the other hand: Why did Ra Therapeutics (recently IPO-ed: RARX) not sell off as well, or even more so? In my books ACHN's oral factor D inhibitor poses more of a challenge to RARX's subcutaneous terminal complement inhibitor, than to CCXI's oral C5aR-antagonist. Or was RARX "insulated" by its own preclinical factor D inhibitor program?

    At any rate, what is currently going on in some small caps is exaggerated. There are some cheap opportunities to pick up shares of individual companies (even though the carnage can go on, as it does every felt 6 months or so...)
    FWIW
    Dr John
  • G
    Gary
    Gary
    what the ????
  • K
    Kenyon
    Kenyon
    The Top Newsletter for NASDAQ & NYSE cheapies that make HUGE GAINS --> go to Penny St0cklOl.0rg
  • R
    Rachel
    Rachel
    Who says CCXI isn't poised for potentially massive upward movement? Not sure how awesom*sto-cks finds all these incredible trade ideas but im happy.
  • F
    FP mcK
    FP mcK
    Anyone have any idea why the stock cratered today? I saw a story about how diet may be used to prevent FSGS on Stat, but really doubt that is the cause.
  • G
    Gary
    Gary
    after the run-up I think it's just people grabbing profits and running for the door with talk of war with NK's KIm Junk ...
  • S
    StacksONStackS
    StacksONStackS
    Is this a good time to buy more?
  • A
    Antoine
    Antoine

    www.PennySt0ckl0l.org is one of the best “alerts” services I have found. Just sign up and watch from the sidelines, you will see!

  • i
    itssofine2
    itssofine2
    Let's see if this will go up to the mid -high teens where it belongs.
  • M
    Myer
    Myer

    www.PennySt0ckl0l.org is one of the best “alerts” services I have found. Just sign up and watch from the sidelines, you will see!

  • S
    StacksONStackS
    StacksONStackS
    Up big today. Anyone know whats going on?
  • R
    Renaldo
    Renaldo

    Found a great no fee daytrading newsletter, vist www.PennySt0ckl0l.org and sign up...so glad I did

  • T
    Tom
    Tom
    Major accumulation goin on here....way under the radar, something big is coming and someone knows about it...I just added another 1k......5k shs baby!!!!!!
  • R
    Robert
    Robert
    Be careful here I've been invested in CCXI for three years. They have a PII additional data reading coming out for CCX872.
  • T
    Tom
    Tom
    wow, getting more powerful......let's move to new base of 12-14....come on with the news.....I know its out there, unless we are getting head faked by traders....
  • T
    Tom
    Tom
    So volume has been above the daily avg for the past few weeks, stock has almost moved 50% from the high 6's......something good has top be coming......this thing wants higher....
  • T
    Tom
    Tom
    Looking good, volume still lower but accumulation underway.......come on CCXI.....let's blow past 10 to the 12-15 range....settle down, announce stellar results and then get bought by VIFOR!!!!!
  • S
    Steve
    Steve
    Did everyone see the confidential treatment orders filed with the SEC on June 20 and June 29? Those filings, along with the receipt of EU Orphan designation for Avacopan, and the accumulation of shares that's been underway for the past month seem to suggest good things for CCXI. I think that it's possible that we may see the announcement of another development/licensing deal. We shall see. I've been watchful of the company over the past year since the collapse of the stock and have been fascinated by the rebuild back to the $7-$9 range. The Vifor deal was key and the addition of Henry McKinnell to the board last fall was intriguing. In my experience, someone of McKinnell's experience, as former CEO and chair of Pfizer, doesn't get involved with a company unless there is some real upside. In fact, McKinnell is likely bringing fresh ideas to the company in addition to his credibility. Further, he is likely help open the doors to new relationships that could propel the company forward. We shall see. Good luck to all.
  • c
    culleraa
    culleraa
    Avacopan P3 underway for over 6m and no word on first treatment of patients. In May was said to be very soon. Trial site says full primary data not until mid 2019. Primary endpoint is remission at 26 w, so either a helluva long time to recruit 300 or being coy about whether 26 w data will be announced?
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    CCXI is up 5.77% to 7.52